Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

349 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Plain language summary of the results from the TALAPRO-2 study: Talazoparib plus enzalutamide versus placebo plus enzalutamide for patients with advanced prostate cancer.
Agarwal N, Azad AA, Carles J, Fay AP, Matsubara N, Heinrich D, Szczylik C, Giorgi U, Joung JY, C Fong PC, Voog E, Jones RJ, Shore ND, Dunshee C, Zschäbitz S, Oldenburg J, Lin X, Healy CG, Santo ND, Zohren F, Fizazi K. Agarwal N, et al. Among authors: heinrich d. Future Oncol. 2024 Jul 12:1-13. doi: 10.1080/14796694.2024.2362108. Online ahead of print. Future Oncol. 2024. PMID: 38995237
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
Smith MR, Saad F, Chowdhury S, Oudard S, Hadaschik BA, Graff JN, Olmos D, Mainwaring PN, Lee JY, Uemura H, Lopez-Gitlitz A, Trudel GC, Espina BM, Shu Y, Park YC, Rackoff WR, Yu MK, Small EJ; SPARTAN Investigators. Smith MR, et al. N Engl J Med. 2018 Apr 12;378(15):1408-1418. doi: 10.1056/NEJMoa1715546. Epub 2018 Feb 8. N Engl J Med. 2018. PMID: 29420164 Free article. Clinical Trial.
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.
Motzer RJ, Escudier B, McDermott DF, George S, Hammers HJ, Srinivas S, Tykodi SS, Sosman JA, Procopio G, Plimack ER, Castellano D, Choueiri TK, Gurney H, Donskov F, Bono P, Wagstaff J, Gauler TC, Ueda T, Tomita Y, Schutz FA, Kollmannsberger C, Larkin J, Ravaud A, Simon JS, Xu LA, Waxman IM, Sharma P; CheckMate 025 Investigators. Motzer RJ, et al. N Engl J Med. 2015 Nov 5;373(19):1803-13. doi: 10.1056/NEJMoa1510665. Epub 2015 Sep 25. N Engl J Med. 2015. PMID: 26406148 Free PMC article. Clinical Trial.
A randomized, open-label, phase 3 trial of pembrolizumab plus epacadostat versus sunitinib or pazopanib as first-line treatment for metastatic renal cell carcinoma (KEYNOTE-679/ECHO-302).
Lara PN Jr, Villanueva L, Ibanez C, Erman M, Lee JL, Heinrich D, Lipatov ON, Gedye C, Gokmen E, Acevedo A, Semenov A, Park SH, Gafanov RA, Kose F, Jones M, Du X, Munteanu M, Perini R, Choueiri TK, Motzer RJ. Lara PN Jr, et al. Among authors: heinrich d. BMC Cancer. 2024 Jul 25;23(Suppl 1):1253. doi: 10.1186/s12885-023-10971-7. BMC Cancer. 2024. PMID: 39054430 Free PMC article. Clinical Trial.
Endothelial epoxyeicosatrienoic acid release is intact in aldosterone excess.
Meng Y, Bilyal A, Chen L, Mederos Y Schnitzler M, Kocabiyik J, Gudermann T, Riols F, Haid M, Marques JG, Horak J, Koletzko B, Sun J, Beuschlein F, Heinrich DA, Adolf C, Reincke M, Schneider H. Meng Y, et al. Among authors: heinrich da. Atherosclerosis. 2024 Sep 5;398:118591. doi: 10.1016/j.atherosclerosis.2024.118591. Online ahead of print. Atherosclerosis. 2024. PMID: 39277963 Free article.
Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146.
Lee CH, Yogesh Shah A, Rao A, Taylor MH, Di Simone C, Hsieh JJ, Pinto A, Gironés Sarrió R, Lee Cohn A, Asim Bilen M, Gunnestad Ribe S, Krohn Tennøe Ø, Richards D, Sweis RF, Courtright J, Heinrich D, Perini R, Kubiak P, Bock D, Okpara CE, Motzer RJ. Lee CH, et al. Among authors: heinrich d. Eur Urol. 2024 May 21:S0302-2838(24)02345-5. doi: 10.1016/j.eururo.2024.05.003. Online ahead of print. Eur Urol. 2024. PMID: 38777648 No abstract available.
Assessing Lateralization Index of Adrenal Venous Sampling for Surgical Indication in Primary Aldosteronism.
Kobayashi H, Nakamura Y, Abe M, Ragnarsson O, Gkaniatsa E, Grytaas MA, Løvås K, Wada N, Ichijo T, Heinrich DA, Drake W, O'Toole S, Kocjan T, Kastelan D, Kraljevic I, Yamamoto K, Tsuiki M, Kloock S, Dischinger U, Parasiliti-Caprino M, Sven G, Spyroglou A, Furnica RM, Fallo F, Maiolino G, Kometani M, Wu VC, Beuschlein F, Reincke M, Naruse M. Kobayashi H, et al. Among authors: heinrich da. J Clin Endocrinol Metab. 2024 May 15:dgae336. doi: 10.1210/clinem/dgae336. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 38747468
Hepatic insufficiency in two juvenile dogs with histoplasmosis.
Whitman RE, Cagle LA, Bosch S, Alas OB, Vilaplana Grosso FR, Lanier CJ, Heinrich DA, Sharkey LC. Whitman RE, et al. Among authors: heinrich da. Vet Clin Pathol. 2024 Jun;53(2):242-249. doi: 10.1111/vcp.13354. Epub 2024 Apr 29. Vet Clin Pathol. 2024. PMID: 38684471
349 results